Shell Asset Management’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-9,965
| Closed | -$96K | – | 1259 |
|
2023
Q2 | $96K | Hold |
9,965
| – | – | ﹤0.01% | 1129 |
|
2023
Q1 | $123K | Hold |
9,965
| – | – | 0.01% | 1054 |
|
2022
Q4 | $123K | Hold |
9,965
| – | – | 0.01% | 1102 |
|
2022
Q3 | $122K | Hold |
9,965
| – | – | ﹤0.01% | 1155 |
|
2022
Q2 | $129K | Hold |
9,965
| – | – | ﹤0.01% | 1222 |
|
2022
Q1 | $134K | Hold |
9,965
| – | – | ﹤0.01% | 1245 |
|
2021
Q4 | $132K | Hold |
9,965
| – | – | ﹤0.01% | 1294 |
|
2021
Q3 | $132K | Sell |
9,965
-410
| -4% | -$5.43K | ﹤0.01% | 1272 |
|
2021
Q2 | $135K | Hold |
10,375
| – | – | ﹤0.01% | 1313 |
|
2021
Q1 | $135K | Buy |
10,375
+218
| +2% | +$2.84K | ﹤0.01% | 1231 |
|
2020
Q4 | $140K | Buy |
10,157
+8,496
| +511% | +$117K | ﹤0.01% | 1211 |
|
2020
Q3 | $24K | Buy |
1,661
+516
| +45% | +$7.46K | ﹤0.01% | 1365 |
|
2020
Q2 | $19K | Sell |
1,145
-1,655
| -59% | -$27.5K | ﹤0.01% | 1369 |
|
2020
Q1 | $40K | Hold |
2,800
| – | – | ﹤0.01% | 1181 |
|
2019
Q4 | $57K | Sell |
2,800
-2,258
| -45% | -$46K | ﹤0.01% | 1204 |
|
2019
Q3 | $27K | Hold |
5,058
| – | – | ﹤0.01% | 1225 |
|
2019
Q2 | $33K | Sell |
5,058
-142
| -3% | -$926 | ﹤0.01% | 1207 |
|
2019
Q1 | $34K | Hold |
5,200
| – | – | ﹤0.01% | 1182 |
|
2018
Q4 | $35K | Hold |
5,200
| – | – | ﹤0.01% | 1125 |
|
2018
Q3 | $34K | Hold |
5,200
| – | – | ﹤0.01% | 1148 |
|
2018
Q2 | $30K | Hold |
5,200
| – | – | ﹤0.01% | 1101 |
|
2018
Q1 | $27K | Buy |
5,200
+1,100
| +27% | +$5.71K | ﹤0.01% | 1111 |
|
2017
Q4 | $19K | Buy |
+4,100
| New | +$19K | ﹤0.01% | 1106 |
|